PUBLIC CONTRACT · 2024

Vários medicamentos

Contract value: €53,555.27
Signed on: 17 December 2024
Procedure: Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 11138788

PUBLISHED DESCRIPTION

41022524 - AQ URGENTE MEDICAMENTOS

Parties involved

Contracting body: Unidade Local de Saúde da Arrábida, E. P. E.
Awardee: DUX PHARMA Unipessoal , LDA.; BAYER PORTUGAL, SA.; GLAXOSMITHKLINE - PROD. FARMACEUTICOS; UCB PHARMA (Produtos Farmacêuticos) Lda.; SMITH & NEPHEW, LDA.; Accord Healthcare, Unipessoal Lda; considerável vantagem lda; INOVEMED – PRODUTOS FARMACEUTICOS; VIFOR PHARMA PORTUGAL, S.A.; PIERRE FABRE MEDICAMENT PORTUGAL, LDA.; BAXTER MEDICO – FARMACEUTICA; MYLAN, LDA.; SANDOZ FARMACÊUTICA, LDA.; AstraZeneca - Produtos Farmacêuticos, Lda.; - - Laboratório Urgo; BIOGEN IDEC PORTUGAL; GENERIS – FARMACEUTICA, S.A.
Place of performance: Portugal, Setúbal, Setúbal
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: DUX PHARMA Unipessoal , LDA. · Tax ID 510803679
Awardee: BAYER PORTUGAL, SA. · Tax ID 500043256
Awardee: GLAXOSMITHKLINE - PROD. FARMACEUTICOS · Tax ID 500139962
Awardee: UCB PHARMA (Produtos Farmacêuticos) Lda. · Tax ID 500291322
Awardee: SMITH & NEPHEW, LDA. · Tax ID 503552461
Awardee: Accord Healthcare, Unipessoal Lda · Tax ID 508622263
Awardee: considerável vantagem lda · Tax ID 513751475
Awardee: INOVEMED – PRODUTOS FARMACEUTICOS · Tax ID 513038876
Awardee: VIFOR PHARMA PORTUGAL, S.A. · Tax ID 516677586
Awardee: PIERRE FABRE MEDICAMENT PORTUGAL, LDA. · Tax ID 500230366
Awardee: BAXTER MEDICO – FARMACEUTICA · Tax ID 503347345
Awardee: MYLAN, LDA. · Tax ID 502248793
Awardee: SANDOZ FARMACÊUTICA, LDA. · Tax ID 506985261
Awardee: AstraZeneca - Produtos Farmacêuticos, Lda. · Tax ID 502942240
Awardee: - - Laboratório Urgo
Awardee: BIOGEN IDEC PORTUGAL · Tax ID 506415740
Awardee: GENERIS – FARMACEUTICA, S.A. · Tax ID 508107997

Matches in the records

MYLAN, LDA. and VIFOR PHARMA PORTUGAL, S.A. share an address · Source: TED (Jornal Oficial da UE), aviso 604352-2025 · Source: TED (Jornal Oficial da UE), aviso 349614-2026

Address and group matches come from the records cited and say only what those records show.

Values and timeline

Contract price: €53,555.27
Procedure base price: €53,555.27
Total effective price: Not reported on Portal BASE
Publication date: 8 January 2025
Award date: 17 December 2024
Signing date: 17 December 2024
Performance period: 12 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Direct award, general (Ajuste Direto Regime Geral)
Award criterion: Monofator
CPV code: 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
Legal basis: Artigo 24.º, n.º 1, alínea c) do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement: Not stated
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 7400372

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts